Browsing by Subject "Valvular heart disease"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Highlights of the Virtual Society for Cardiovascular Magnetic Resonance 2022 Scientific Conference: CMR: improving cardiovascular care around the world
    (Elsevier, 2022-01) Ojha , Vineeta; Khalique, Omar K.; Khurana , Rishabh; Lorenzatti , Daniel; Leung , Steve W.; Lawton , Benny; Slesnick , Timothy C.; Cavalcante , Joao C.; Ducci , Chiara-Bucciarelli; Patel , Amit R.; Prieto, Claudia C.; Plein , Sven; Raman , Subha V.; Salerno, Michael; Parwani , Purvi; Medicine, School of Medicine
    The 25th Society for Cardiovascular Magnetic Resonance (SCMR) Annual Scientific Sessions saw 1524 registered participants from more than 50 countries attending the meeting virtually. Supporting the theme “CMR: Improving Cardiovascular Care Around the World”, the meeting included 179 invited talks, 52 sessions including 3 plenary sessions, 2 keynote talks, and a total of 93 cases and 416 posters. The sessions were designed so as to showcase the multifaceted role of cardiovascular magnetic resonance (CMR) in identifying and prognosticating various myocardial pathologies. Additionally, various social networking sessions as well as fun activities were organized. The major areas of focus for the future are likely to be rapid efficient and high value CMR exams, automated and quantitative acquisition and post-processing using artificial intelligence and machine learning, multi-contrast imaging and advanced vascular imaging including 4D flow.
  • Thumbnail Image
    Item
    Racial, Ethnic, and Gender Disparities in Valvular Heart Failure Management
    (Elsevier, 2023) Ilonze, Onyedika; Free, Kendall; Shinnerl, Alexander; Lewsey, Sabra; Breathett, Khadijah; Medicine, School of Medicine
    Racial, ethnic, and gender disparities are present in the diagnosis and management of valvular heart disease. The prevalence of valvular heart disease varies by race, ethnicity, and gender, but diagnostic evaluations are not equitable across the groups, which makes the true prevalence less clear. The delivery of evidence-based treatments for valvular heart disease is not equitable. This article focuses on the epidemiology of valvular heart diseases associated with heart failure and the related disparities in treatment, with a focus on how to improve delivery of nonpharmacological and pharmacological treatments.